As synthetic intelligence, gene therapies, and medical-grade digital well being instruments enter the well being care scene, new boundaries are being redrawn round what is feasible in medication. Roughly 10 years into the digital well being document experiment, how should this know-how evolve to take full benefit of those thrilling developments? This session will deal with constructing subsequent-technology capabilities into EHRs to maintain tempo with developments in know-how and science. It can even look at new alternatives for EHRs to ship affected person care that’s customized, predictive, preventive, and delicate to the social and behavioral influences over an individual’s well being. From the 2018 EHR National Symposium at Stanford.
* Amy Abernathy, MD, PhD, Flatiron
* Taylor Davis, KLAS
* Lloyd Minor, MD, dean of the Stanford University School of Medicine
* Judy Murphy, IBM Global Healthcare
* Donald Rucker, MD, U.S. Department of Health and Human Services
Moderator: Reed Abelson, The New York Times
For extra on the symposium: http://med.stanford.edu/ehr/research.html